JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Joachim Pfannschmidt
Hendrik Dienemann
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johney, E. C.
Right arrow Articles by Dienemann, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johney, E. C.
Right arrow Articles by Dienemann, H.

J Thorac Cardiovasc Surg 2006;131:1207-1208
© 2006 The American Association for Thoracic Surgery


Brief Communication

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and a typical carcinoid tumor

Elizabeth Chittilappilly Johney, MD a , Joachim Pfannschmidt, MD a , * , Ralf Joachim Rieker, MD b , Philipp Albert Schnabel, MD, PhD b , Gunhild Mechtersheimer, MD, PhD b , Hendrik Dienemann, MD, PhD a

a Department of Thoracic Surgery, Heidelberg University, Heidelberg, Germany
b Department of Pathology, Heidelberg University, Heidelberg, Germany

Received for publication November 10, 2005; revisions received December 9, 2005; accepted for publication December 16, 2005.

* Address for reprints: J. Pfannschmidt, MD, Department of Surgery, Thoraxklinik Heidelberg, Amalienstr. 5, D-69126 Heidelberg, Germany (Email: joachim.pfannschmidt{at}thoraxklinik-heidelberg.de).

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is regarded as a precursor to the development of carcinoid tumorlet and carcinoid tumor. It is confined to the neuroendocrine cell hyperplasia of the airway mucosa without penetration through the basement membrane and appears in a diffuse pattern, typically in association with obliterative bronchiolar fibrosis. DIPNECH belongs to the preinvasive lesions defined by the 1999 World Health Organization classification, including atypical adematous hyperplasia and squamous dysplasia–carcinoma in situ.

Clinical Summary

A 73-year-old female nonsmoker was known to have intermittent hemoptysis for several years. The family history and past medical history were noncontributory beside a chronic dry cough in part accompanied by mucous expectoration and a higher frequency of pulmonary infections in the past years.

Previous chest radiography showed no underlying causes of the clinical symptoms anamnestically. Contrast-enhanced spiral chest computed tomographic examination revealed no apparent tumor mass. Although bronchiectasis was multisegmental, the middle lobe appeared to be most affected (Figure 1). During an acute episode of hemoptysis, bronchoscopy revealed the superior segmental bronchus (B6) of the right lobe to be the source of bleeding.


Figure 1
View larger version (170K):
[in this window]
[in a new window]
 
Figure 1. Computed tomographic scan showing noncharacteristic infiltrates and bronchiectasis of the middle lobe.

 
Spirometry revealed a forced expiratory volume in 1 second of 69.1% of predicted value, a forced vital capacity of 78.5% of predicted value, and a forced expiratory volume in 1 second/forced vital capacity ratio of 0.73. Because of the severe episodes of hemorrhages and recurrent chest infections, the patient was scheduled to undergo thoracotomy.

No endobronchial lesion or bleeding was seen at repeated bronchoscopy before intubation for pulmonary resection. Subtotal obstruction of the right middle lobe was caused by mucus. For a more limited resection, the patient underwent a right middle lobectomy and systematic mediastinal and hilar lymph node dissection.

Pathology revealed diffuse neuroendocrine cell hyperplasia, especially in the peribronchial region (Figure 2), as well as tumorlet formation and a 1.2-cm typical carcinoid tumor. The resected hilar and mediastinal lymph nodes were negative for metastatic disease and had normal lymph node architecture. The postoperative recovery was uneventful, and 3 months after surgical intervention, she is stable with no pulmonary nodules on chest radiography.


Figure 2
View larger version (179K):
[in this window]
[in a new window]
 
Figure 2. Microscopic appearance of DIPNECH: small groups and nodular aggregates of tumor cells associated with the bronchiolar epithelium. (Original magnification 40x; hematoxylin and eosin staining.)

 
Discussion

DIPNECH is a rarely described lesion. The term diffuse idiopathic pulmonary neuroendocrine cell hyperplasia refers to collections of scattered single cells, small nodules, or linear proliferations of neuroendocrine cells confined to the airway mucosa. It is reserved only for cases in which the hyperplasia is diffuse and primary in nature. It is regarded as a precursor to the development of carcinoid tumorlet (diameter <5 mm) or carcinoid tumor (diameter >5 mm). The diagnosis requires the presence of hyperplasia of the airway neuroendocrine cells without invasion beyond the basement membrane. It occurs in association with chronic inflammation or fibrosis. 1 Go

Clinical symptoms, specific pathologic features, and the reported predilection for middle-aged or older nonsmoking women matched with the finding of DIPNECH. 3,4 Go This is consistent with publications by Ruffini and associates 2 Go and Swigris and colleagues. 3 Go

The role of hormonal modulation in this disease has been suggested by Swigris and colleagues, 3 Go but further studies are pending.

In our case the serum neuron-specific enolase level was within the normal values; nevertheless, the results of the immunohistochemical examination of the tissue was positive for neuron-specific enolase. The clinical picture of obliterative bronchiolitis and airway hyperreactivity is thought to be correlated to peptide secretory substances. Because hyperplastic neuroendocrine cells contain a variety of neuropeptides, including bombesin-like peptides, these are likely to be important in the pathogenesis. 4 Go

Although there are few reported cases, the prevalence of DIPNECH might be higher than it is supposed to be because there were no definition criteria until very recently, and the issue remains controversial. 2 Go A high index of suspicion is required to recognize this entity. 3 Go

Little is known of the clinical evolution and treatment options for DIPNECH. Therefore Swigris and colleagues 3 Go presented 4 patients with 2- to 14-year follow-up and found an excellent long-term prognosis.

The management of patients with DIPNECH is predominantly close surveillance; the role of surgical intervention is not clearly defined. Worsening of obstructive symptoms (or in our case recurrent pulmonary hemorrhage) can be dealt with by means of palliative resection. In patients with carcinoid tumor formation, complete resection of the carcinoid tumor with lung preservation surgery, accompanied by a systematic mediastinal and hilar lymph node dissection, forms the basic treatment opinion.

In patients in whom DIPNECH continues to progress to carcinoid tumors and in whom surgical options run out, somatostatin analogs and interferon {alpha} might have a role as tumerostatic agents. 5 Go

In conclusion, long-term follow up is mandatory to detect the formation of early carcinoid tumors.

References

  1. Kerr KM. Pulmonary preinvasive neoplasia. J Clin Pathol 2001;54:257-271.[Abstract/Free Full Text]
  2. Ruffini E, Bongiovanni M, Cavallo A, et al. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms. Eur J Cardiothorac Surg 2004;26:165-172.[Abstract/Free Full Text]
  3. Swigris J, Ghamande S, Rice T, Farver C. Diffuse idiopathic neuroendocrine cell hyperplasia. an interstitial lung disease with airway obstruction. J Bronch 2005;12:62-64.
  4. Cohen AJ, King TE, Gilman LB, et al. High expression of neutral endopeptidase in idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells. Am J Respir Crit Care Med 1998;158:1593-1599.[Abstract/Free Full Text]
  5. Saltz L. Octreotide as an antineoplastic agent in the treatment of functional and non-functional neuroendocrine tumors. Cancer 1993;72:244-248.[Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Joachim Pfannschmidt
Hendrik Dienemann
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johney, E. C.
Right arrow Articles by Dienemann, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johney, E. C.
Right arrow Articles by Dienemann, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS